Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01731236 · ClinicalTrials.gov registry record · Early Phase 1

CARNIVAL Study: Gut Flora Dependent Metabolism of Dietary CARNItine and Phosphatidylcholine and cardioVAscuLar Disease

A Early Phase 1 study of Dietary Modification, sponsored by The Cleveland Clinic.

Active
Registry status
Early Phase 1
Development phase
100
Enrollment target
1
Study location

NCT01731236 is a Early Phase 1 study of Dietary Modification that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 100 participants, below the 217-participant average among 5 other Dietary Modification trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01731236, a Early Phase 1 study of Dietary Modification, is active but no longer recruiting, sponsored by The Cleveland Clinic.

ACTIVE NOT RECRUITING
Registry status
Early Phase 1
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The principal goal for the study is to examine the role gut flora plays in modulating metabolism of dietary carnitine and choline in humans.

Conditions Studied

Interventions

  • DRUG Antibiotics
  • DIETARY_SUPPLEMENT Choline
  • DIETARY_SUPPLEMENT Carnitine
  • DRUG Choline and Aspirin
  • DRUG Carnitine and Aspirin

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2011-02-11
Est. Completion 2029-12
Phase Early Phase 1

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT01731236

The ClinicalTrials.gov registry entry for NCT01731236 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 217-participant average among 5 other Dietary Modification trials with a reported enrollment target (54% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dietary Modification appearing as the primary indexed condition, and to 5 interventions - of which Antibiotics is the first listed.

NCT01731236 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT01731236 about?

NCT01731236 is a clinical study titled "CARNIVAL Study: Gut Flora Dependent Metabolism of Dietary CARNItine and Phosphatidylcholine and cardioVAscuLar Disease". The principal goal for the study is to examine the role gut flora plays in modulating metabolism of dietary carnitine and choline in humans.

What is the current status of trial NCT01731236?

This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 100 participants. The study started on 2011-02-11. Estimated completion is 2029-12.

What conditions does trial NCT01731236 study?

This clinical trial studies the following conditions: Dietary Modification.

What interventions are being tested in trial NCT01731236?

The interventions under investigation include: Antibiotics (DRUG), Choline (DIETARY_SUPPLEMENT), Carnitine (DIETARY_SUPPLEMENT), Choline and Aspirin (DRUG), Carnitine and Aspirin (DRUG).

Who is sponsoring clinical trial NCT01731236?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01731236 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dietary Modification

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.